Chemotherapy for prostate cancer
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Weekly docetaxel and estramustine in patients with hormonerefractory prostate cancerSeminars in Oncology, 2001
- Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary reportSeminars in Oncology, 2001
- Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate CancerNew England Journal of Medicine, 1998
- Oral estramustine and oral etoposide for hormone-refractory prostate cancerUrology, 1997
- A phase ii trial of oral estramustine and oral etoposide in hormone refractory prostate cancerUrology, 1997
- Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell linesBritish Journal of Urology, 1997
- Symptomatic Improvement Associated With Combined Estramustine and Vinblastine Chemotherapy for Metastatic Prostate CancerAmerican Journal of Clinical Oncology, 1996
- Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivoUrology, 1996
- Suramin-Induced Decrease in Prostate-Specific Antigen Expression With No Effect on Tumor Growth in the LNCaP Model of Human Prostate CancerJNCI: Journal of the National Cancer Institute, 1996
- Mechanisms of Action and Clinical Uses of EstramustineCancer Investigation, 1990